Proposal of a novel pND-based staging system for locoregional gastric neuroendocrine carcinoma: A multicenter retrospective study.
Abstract
624 Background: Gastric neuroendocrine carcinoma (NEC) is a rare, aggressive malignancy lacking a disease-specific staging system. Our previous multicenter analysis showed therapeutic value of D1 lymphadenectomy, limited benefit of D2, and the prognostic impact of nodal area involvement (pND). The UICC TNM classification (7th edition), based on metastatic node count (pN), had poor prognostic discrimination. We aimed to propose a pND-based staging system and compare its prognostic performance with the UICC TNM classification. Methods: Data of 118 patients with gastric NEC (n=79) or mixed adenoneuroendocrine carcinoma (n=39) who underwent gastrectomy with ≥D1 dissection at 29 Japanese centers (2000–2015) were retrospectively analyzed. Patients with metastasis or preoperative therapy were excluded. Overall survival (OS) and recurrence-free survival (RFS) were estimated by Kaplan–Meier. Prognostic factors were assessed by Cox regression. Model performance was evaluated by likelihood ratio tests, concordance index (C-index), Akaike information criterion (AIC), and Bayesian information criterion (BIC). Results: Median age was 69; 83% male. Five-year OS and 3-year RFS were 56.7% and 63.4%. Older age, female sex, and pND2 were independent adverse prognostic factors. The pND-based system was defined as: Stage A = pT1pND0–1 or pT2–4pND0; Stage B = pT2–4pND1; Stage C = pT2–4pND2. Five-year OS and RFS for A/B/C were 63.5/56.3/40.9% and 58.4/43.7/30.7%. Stage C showed significantly worse OS (HR 2.52, p=0.016) and RFS (HR 2.84, p=0.004) versus Stage A. UICC TNM stages I–III overlapped. Model comparison showed better performance of the pND-based system: OS C-index 0.67 vs 0.62, AIC 498 vs 512, BIC 514 vs 528; RFS C-index 0.65 vs 0.60, AIC 476 vs 489, BIC 492 vs 505. LRT confirmed significant improvement when adding the pND-based stage to UICC TNM, but not vice versa. Conclusions: The pND-based Stage A–C system outperformed the UICC TNM classification (7th edition), offering clearer prognostic stratification. This framework may serve as a disease-specific staging system for gastric NEC and inform surgical and multidisciplinary strategies.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (20)
Yukinori Yamagata
Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan
Mitsuhiro Furuta
Akifumi Notsu
Division of Clinical Research Center, Shizuoka Cancer Center, Nagaizumi, Japan
Hirofumi Yasui
Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan
Rie Makuuchi
Department of Gastroenterological Surgery, Cancer Institute Hospital, Koto-Ku, Japan
Takanobu Yamada
Department of Cardiovascular Medicine (S.N., M.K., T.Y., E.A., K.F., I.K.), University of Tokyo Hospital, University of Tokyo, Japan.
Michihiro Ishida
Department of Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan
Kunihiro Tsuji
Departments of Medical Oncology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan
Shigeaki Baba
Department of Surgery, School of Medicine, Iwate Medical University, Morioka, Japan
Noriaki Tokumoto
Department of Gastroenterological Surgery, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima, Japan
Shusuke Haruta
Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan
Masaya Watanabe
Takuya Hamakawa
Department of Gastroenterological Surgery, Osaka Rosai Hospital, Osaka, Japan
Yasuyuki Kawachi
Department of Surgery, Nagaoka Chuo General Hospital, Niigata, Japan
Norihiko Sugisawa
Department of Surgery, Miyagi Cancer Center, Sendai, Japan
Yukinori Kurokawa
Narikazu Boku
Masanori Terashima
Nozomu Machida
Takaki Yoshikawa
National Cancer Center Hospital, Tokyo, Japan